The jaundice meter, also known as neonatal bilirubinometer or transcutaneous bilirubinometer, is a medical device used to detect jaundice in newborn babies non-invasively. It utilizes the principle of transcutaneous bilirubin measurements to measure bilirubin levels through the skin, helping detect neonatal jaundice without drawing blood samples from babies. The advantages of using a jaundice meter include its non-invasive nature which reduces pain and discomfort for infants. It also provides quick and accurate bilirubin level readings to help physicians monitor and treat jaundice promptly if required.
The Global Jaundice Meter Market is estimated to be valued at US$ 107.24 Mn in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the jaundice meter market are Aegis Medicals, Refine Medical Technology, Delta Medical International, Micro Lab, M&B, Dräger, Xuzhou Kejian Hi-tech, Natus Medical. The major players are focusing on developing innovative and advanced jaundice meters to measure bilirubin levels more precisely.
The demand for jaundice meters is expected to grow significantly during the forecast period owing to the rising incidences of neonatal jaundice worldwide. According to the World Health Organisation (WHO), nearly 60% of newborns develop jaundice worldwide. This high prevalence is expected to drive the sales of jaundice meters across hospitals and clinics.
The Jaundice Meter Market is expanding globally due to the increasing awareness regarding infant healthcare in developing nations and technological advancements in medical devices. The key players are focusing on strengthening their distribution channels in emerging markets of Asia Pacific, Latin America, and Middle East & Africa to tap the growth opportunities in these regions.
Market Key Trends
One of the key trends gaining traction in the jaundice meter market is the development of portable and handheld devices. The major players have launched compact jaundice meters that can be easily carried around hospital wards or home settings. These portable devices are integrated with advanced features like touchscreen operation, data connectivity, and reporting of bilirubin values directly to Electronic Medical Records (EMR). This trend towards miniaturization and portability is expected to support the sales of jaundice meters.
Porter’s Analysis
Threat of new entrants: New companies entering the market face high production and operation costs due to strict regulations.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and standardized products.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative components.
Threat of new substitutes: Substitutes like blood tests pose a competitive threat due to their widespread acceptance.
Competitive rivalry: Companies compete on the basis of product quality, reliability and pricing.
Geographical Regions
North America accounts for the largest share in the global jaundice meter market due to high healthcare expenditure and developed healthcare infrastructure in the US and Canada.
Asia Pacific is expected to exhibit the fastest growth during the forecast period, driven by growing awareness regarding infant health, improving access to healthcare facilities and rising affordability in China and India.